Sept 15, 2022 | DNA, Epigenetics, Genetics, Methylation, Wellness
Ryan Smith, Vice President of Business Development at TruDiagnostic
Aging is the #1 risk factor for all chronic diseases and death. Delaying the aging rate by just 20% could save the US of 3 trillion in healthcare entitlement spending. Since 2013, epigenetic clocks have been the best way to measure the aging process of patients. However, these clocks continue to improve and now methylation clocks are uncovering insights on how we can treat aging and reduce risk of disease and death. We will discuss the newest developments in this testing and how to best use in your clinic to measure aging and improve patient outcomes.
Speaker:
Ryan Smith
Vice President Of Business Development at TruDiagnostic